Literature DB >> 22011286

Prognostic value of initial tumor parameters after metastatic relapse.

E Planchat1, X Durando, C Abrial, E Thivat, M A Mouret-Reynier, J P Ferrière, C Pomel, F Kwiatkowski, P Chollet, J M Nabholtz.   

Abstract

Classical prognostic factors of breast cancer are correlated to disease-free survival and overall survival (OS); their precise role is less known on metastatic disease. A total of 511 breast cancer patients without initial metastasis were treated. OS was divided in time to distant recurrence and metastatic survival (MS). Age, Scarff-Bloom-Richardson (SBR) grade, hormone receptor, axillary node involvement, and Nottingham prognostic index predicted MS in univariate analysis. Multivariate analysis retained age, SBR grade, and axillary lymph node involvement as significant independent prognostic factors. Interactions are still present between initial parameters and MS. The clinician has to take into account for treatment choice.

Entities:  

Mesh:

Year:  2011        PMID: 22011286     DOI: 10.3109/07357907.2011.621911

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  6 in total

1.  Retrospective analysis of metastatic behaviour of breast cancer subtypes.

Authors:  C Dilara Savci-Heijink; Hans Halfwerk; Gerrit K J Hooijer; Hugo M Horlings; Jelle Wesseling; Marc J van de Vijver
Journal:  Breast Cancer Res Treat       Date:  2015-03-29       Impact factor: 4.872

Review 2.  A Systematic Review of Clinical Outcomes and Prognostic Factors for Patients Undergoing Surgery for Spinal Metastases Secondary to Breast Cancer.

Authors:  Daniel M Sciubba; C Rory Goodwin; Alp Yurter; Derek Ju; Ziya L Gokaslan; Charles Fisher; Laurence D Rhines; Michael G Fehlings; Daryl R Fourney; Ehud Mendel; Ilya Laufer; Chetan Bettegowda; Shreyaskumar R Patel; Y Raja Rampersaud; Arjun Sahgal; Jeremy Reynolds; Dean Chou; Michael H Weber; Michelle J Clarke
Journal:  Global Spine J       Date:  2015-10-21

3.  HER2 positivity is not associated with adverse prognosis in high-risk estrogen receptor-positive early breast cancer patients treated with chemotherapy and trastuzumab.

Authors:  Shuai Li; Jiayi Wu; Ou Huang; Jianrong He; Li Zhu; Weiguo Chen; Yafen Li; Xiaosong Chen; Kunwei Shen
Journal:  Breast       Date:  2020-10-15       Impact factor: 4.380

4.  Prognosis and Treatment of Metastatic Breast Cancer From A Real-World Scenario in China: A Retrospective Cohort Study.

Authors:  Yuxin Xie; Ji Ma; Xueming Xia; Hong Zheng; Qiheng Gou
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 2.339

5.  Metastasis-Free Interval Is Closely Related to Tumor Characteristics and Has Prognostic Value in Breast Cancer Patients with Distant Relapse.

Authors:  Hee Jun Kim; Sung Gwe Ahn; Hak Min Lee; Jong Tae Park; Kyunghwa Han; Seung Ah Lee; Joon Jeong
Journal:  J Breast Cancer       Date:  2015-12-23       Impact factor: 3.588

6.  Prognostic Model for De Novo and Recurrent Metastatic Breast Cancer.

Authors:  Carlos H Barcenas; Juhee Song; Rashmi K Murthy; Akshara S Raghavendra; Yisheng Li; Limin Hsu; Robert W Carlson; Debu Tripathy; Gabriel N Hortobagyi
Journal:  JCO Clin Cancer Inform       Date:  2021-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.